Terran Biosciences announces licensing deal with Columbia University for exclusive worldwide rights to proprietary CNS biomarker software platform

Terran Biosciences, Inc. (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics and technologies for neurological and psychiatric diseases, has entered into an agreement with Columbia University (“Columbia”) and the Research Foundation for Mental Hygiene (“RFMH”), to obtain worldwide exclusive rights to develop and commercialize Columbia’s proprietary CNS…

thaipr.net

17 มี.ค. 65

Fitch Affirms Kasikorn Securities at ‘AA(tha)’; Outlook Stable

Fitch Ratings has affirmed Kasikorn Securities Public Company Limited’s (KS) National Long-Term Rating at ‘AA(tha)’ and National Short-Term Rating at ‘F1+(tha)’. The Outlook is Stable. KEY RATING DRIVERSThe ratings are underpinned by support from KS’s parent, KASIKORNBANK Public Company Limited (KBank; BBB/AA+(tha)/Stable). KS is an important part of KBank’s universal banking platform, as the…

thaipr.net

16 มี.ค. 65
1 2,407 2,408 2,409 2,410 2,411 3,330